LIGNOSPAN FORTE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Lignospan Forte, and when can generic versions of Lignospan Forte launch?
Lignospan Forte is a drug marketed by Deproco and is included in one NDA.
The generic ingredient in LIGNOSPAN FORTE is epinephrine bitartrate; lidocaine hydrochloride. There are twenty-one drug master file entries for this compound. Ten suppliers are listed for this compound. Additional details are available on the epinephrine bitartrate; lidocaine hydrochloride profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for LIGNOSPAN FORTE?
- What are the global sales for LIGNOSPAN FORTE?
- What is Average Wholesale Price for LIGNOSPAN FORTE?
Summary for LIGNOSPAN FORTE
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Finished Product Suppliers / Packagers: | 6 |
| Drug Prices: | Drug price information for LIGNOSPAN FORTE |
| DailyMed Link: | LIGNOSPAN FORTE at DailyMed |
Pharmacology for LIGNOSPAN FORTE
| Drug Class | Amide Local Anesthetic Antiarrhythmic Catecholamine alpha-Adrenergic Agonist beta-Adrenergic Agonist |
| Mechanism of Action | Adrenergic alpha-Agonists Adrenergic beta-Agonists |
| Physiological Effect | Local Anesthesia |
US Patents and Regulatory Information for LIGNOSPAN FORTE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Deproco | LIGNOSPAN FORTE | epinephrine bitartrate; lidocaine hydrochloride | INJECTABLE;INJECTION | 088389-001 | Jan 22, 1985 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
